With global markets continuing to slide, expect valuations to shrink and capital raises to get more difficult for the New Haven area’s bioscience companies, a panel of experts said May 18 at the Yale Innovation Summit … more
But enthusiasm for bioscience and startup growth in Connecticut was evident at the event, with top state officials on hand. Participants included pharaceutical giant Pfizer and Nuritas, an Irish company planning to set up its U.S. base in New Haven … more